Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis

Robert J. Tagher, Robert Baumann, Nirmala Desai

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care.

Original languageEnglish
Pages (from-to)233-235
Number of pages3
JournalJournal of Pediatrics
Volume134
Issue number2
DOIs
StatePublished - 1999

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis'. Together they form a unique fingerprint.

Cite this